key: cord-0826123-syq002rr
authors: Terry, Nicolas
title: COVID-19 and healthcare lessons already learned
date: 2020-05-04
journal: J Law Biosci
DOI: 10.1093/jlb/lsaa016
sha: 686b23b7638bfccf75e5d21fc06b0ecebd6a87e1
doc_id: 826123
cord_uid: syq002rr

COVID-19 has exposed deep-rooted flaws in our health system regarding healthcare financing and delivery. This essay uses COVID-19 as a frame to reflect on the growth in our uninsured population, the flaws inherent in healthcare federalism, how “Trumpcare” has made things worse, the magnified importance of Medicaid, and the problems inherent in relying primarily on private actors.

Abstract; COVID-19 has exposed deep-rooted flaws in our health system regarding healthcare financing and delivery. This essay uses COVID-19 as a frame to reflect on the growth in our uninsured population, the flaws inherent in healthcare federalism, how "Trumpcare" has made things worse, the magnified importance of Medicaid, and the problems inherent in relying primarily on private actors.

Article word count; 5411

its failure to address treatment or prescription drug costs and the increasing problem of declining actuarial value in healthcare policies resulting in underinsurance, 6 primarily for middle-income persons with insurance provided by their employers. 7 Relatedly, our national health expenditures have resumed their upward trajectory and are estimated to represent almost 20 percent of the country's gross domestic product before the end of the decade. 8 COVID-19 clearly increased focus on the underinsurance problem, with questions almost immediately voiced as to whether the insured would have to suffer out-of-pocket expenditures for testing, treatment, or hoped-for vaccination. As the pandemic has worsened, attention is once again returning to access to healthcare in the U.S. which still only merits an "Incomplete." The cost and segmented nature of healthcare insurance remain the prevailing problems as persons churn from one insured (or uninsured) state to another, each with different premium and out-ofpocket-costs (some of which are unaffordable) and networks, many of which are narrow enough to generate surprise bills. COVID-19 has emphasized the unfinished work of the ACA, including the need for additional legislation to better integrate marketplaces with Medicaid to provide a more seamless insurance system for all. 6 See, e.g., CHRISTOPHER T. ROBERTSON 

The number of uninsured remains far too high, approaching 30 million, 9 higher than the combined populations of Australia and New Zealand. From a high at the time the ACA was passed, the uninsured rate rapidly declined, only to begin increasing again over the last three years. 10 The Trump Administration's lack of enthusiasm for the ACA marketplaces ("Obamacare"), the failure of some states to expand Medicaid, and the zeroing of the individual mandate penalty 11 must all bear some of the blame.

COVID-19 emphasizes the plight of the uninsured, such as those towards the bottom of the economic pyramid, those who are delivering our groceries and packages but are part-time employees without health insurance. One estimate suggests that hospitals treating the existing uninsured cohort will face uncompensated care in the range of $13.9 billion to $41.8 billion 12

with the high end of the estimate poised to consume over forty percent of funds set aside for hospitals by the CARES Act. 13

Even more critically, the increasing economic toll of the pandemic will lead to millions of Americans losing both their jobs and their employer-provided health insurance. There is little guarantee that all-or even many-of these jobs will return. One study found that the number of people receiving employment-based coverage has already declined by 1.5 million and projects a and has led to an incoherent mix of financing models and reimbursement policies.

During normal times, fiscal hawks frequently hold sway in Washington, seeking to reduce the federal healthcare financial footprint and threatening the most vulnerable with "reforms" such as work requirements and block grants. 18 Outside of the norm, we see short term, additional funding during national emergencies such as the opioid overdose epidemic 19 and, now, Beyond these temporary occasions of generosity, the federal government has little enduring interest or ability in tackling major structural problems. For example, in a 2018 speech, HHS Secretary Azar recognized how little has been achieved in tackling the social determinants of health, highlighting the need to "do a better job of aligning federal health investments with our investments in non-healthcare needs." 21 Yet, he recognized that the structural impediments are massive; federal programs designed to help the vulnerable are spread across multiple agencies, frequently administered at the state level, and often are not even provided by government but depend on NGOs such as charities.

While critics on the right like to refer to the ACA as a federal government takeover of healthcare, at most it was an expansion of health insurance regulation. Even given that limited frame, it was flawed because the shadow of ERISA continues to support regulatory fragmentation as states look to fill in the ACA's gaps. 22 Perhaps, the failure of federalism (both healthcare and public health), aided in large part by the Supreme Court in Nat'l Fed'n of Indep. Bus. v. Sebelius, 23 is best illustrated by the patchwork expansion of Medicaid that, once again, emphasized that where Americans live is likely determinative of their access to healthcare. As COVID-19 has spread from the cities to already underserved rural counties, the failure of some states to issue timely stay-at-home orders began to coalesce with the problem of large numbers of uninsured persons. 24 For too many, zip-code healthcare will morph into zip-code infection or mortality. To quote Nicole Huberfeld, "any assumption that states make better health choices is detached from history's lessons." 25 Even in what is beyond doubt a national emergency, the federal government has eschewed its leadership role. Indeed, frequently, the rhetoric of favoring "surgical" interventions is code for pushing the decision down to states or even localities. Worse, the federal government seems to 22 

moved to outlaw skinny plans 37 and the federal rule is being challenged in the courts. 38 There is also a dearth of data as to exactly what coverages skinny plans offer given the absence of essential health benefit or preexisting condition requirements. 39 There should be real concern that persons who were coaxed into buying these plans by the Trump Administration will now find themselves holding almost worthless policies when gauged against the likely costs of COVID-19 treatment beyond the initial testing.

The administration also continued to promote the Bush Administration model of HSAs combined with high deductible catastrophic plans. Finally, although it did not necessarily cause the problem of rapidly increasing out-of-pocket expenses and the attendant rise in the number of underinsured persons, 40 clearly the administration has done nothing to solve it.

As COVID-19 developed, Congress passed bipartisan legislation that implicitly ridicules some of these elements of " 

failed, the Trump Administration's CMS adopted a related agenda, also designed to reduce the Medicaid budget, but by reducing the number of eligible persons. This "work requirement" strategy, which was, at its philosophical core, an attempt to reframe Medicaid as welfare rather than health insurance, was to be implemented by approving Section 1115 waiver requests from states. 47 As is well-known, the administration's plans were put on ice by a combination of the It is Medicaid 101 that a recession, let alone one caused by an almost total shut down of economic life and vastly increased unemployment, will, in true counter-cyclical fashion, trigger increased demand for Medicaid, while state revenues decline. 50 However, COVID-19 provides further evidence that, in national health emergencies, Medicaid is an incredibly important initial response. For example, after Hurricane Katrina, the Bush administration removed the eligibility requirements for Medicaid benefits. 51 Medicaid was also a major part of the federal government's response to the opioid overdose epidemic. 52

The same has been true with COVID-19. Although CMS has resisted calls to follow the Bush model and liberalize eligibility, it has granted a large number of Section 1135 waivers that, for example, suspend prior authorization requirements or relax provider enrollment rules. 53 CMS has also begun approving Section 1115 waivers targeting specific COVID-19 needs. 54 The Families

First Coronavirus Response Act provided COVID-19 testing for Medicaid recipients without cost-sharing 55 and introduced a temporary 6.2 percent increase in the FMAP, the federal government's contribution to Medicaid. 56 As if more evidence was needed, the pandemic has demonstrated the vital role that Medicaid plays in providing not only health care but also health resilience, normalizing access to services. 57 As already noted and doubling down on the cruel natural experiment 58 

original ACA 100 percent enhanced match for three years to bring those holdout states into the fold. 66 Massive increases in the numbers of unemployed and uninsured will cement Medicaid as the most important healthcare insurance in the country and, hopefully, will reduce calls from the right for its dismemberment.

The daily dueling televised briefings by the Trump administration and the nation's governors may have reflected disagreements over federal and state powers and responsibilities. 67 Under the surface, however, they also illustrate the fundamental fragility of a healthcare system that, some financing and regulation aside, is fundamentally one implemented by private actors interacting in a poorly functioning market model.

Those who tout the excellence of the U.S. healthcare, damning evidence to the contrary notwithstanding, 68 frequently look to markets and competition as the keys to innovation, cost reduction, and improved quality. 69 However, private healthcare entities (be they non-profits or for-profits) lack incentives to address the social determinants of health, to build community resilience, to construct wraparound service, or to invest in healthcare solidarity to achieve herdbased improvements to the health of all.

Of course, there are regulatory "nudges," such as the ACA's Hospital Readmissions Reduction

Program 70 and the requirement that non-profit hospitals perform community health needs assessments. 71 However, these seem to have had little impact on our deep structural problems.

These are problems that require centralized intervention and are not issues addressable by the private actors in our deeply fragmented healthcare system or, as argued above, most of our states.

Take, for example, rural populations, which continue to see their healthcare needs rise while their hospital and provider resources are hollowed out. 72 Medicaid expansion 73 and DSH payments 74 help, but only centralized government can sustain a comprehensive rural healthcare system.

COVID-19 not only illustrates how private actors failed to invest in prophylactic structures but also their relatively poor performance once the pandemic arrived. For example, stories have emerged of chaotic responses by for-profit private healthcare systems that were reducing supplies and overworking staff even before the virus hit. 75 Reliance on diffuse private entities who are also competitors is also responsible for much of the fragmentation in our healthcare system. As the situation in New York worsened in March 2020, Governor Cuomo announced a

statewide public-private hospital plan to fight COVID-19. This essentially merged the 200 entities, allowing them to share supplies and staff and balance capacity. 76 The negatives inherent in the U.S. private system extend beyond delivery to financing. For example, when a system is designed around third-party reimbursement, it may have to shutter and furlough staff during a national emergency-a peculiar irony as hospital staff are let go during a time when our healthcare resources are overwhelmed. 77 Equally, the friction caused by the interaction of private insurance companies and providers is brought into stark relief during a pandemic, when quick responses; innovation in delivery, such as using tele-health; and speedy authorization are missing. 78 COVID-19 has magnified the dysfunction inherent in the publicprivate model, such as when vindictive politicians instruct suppliers not to send needed supplies to a particular state. 79 Needless to say, generalizations are never perfect. A public, top-down, integrated system also will falter in the face of a pandemic if the chosen strategy is flawed, as has been the case in the United Kingdom. 80 If there is one overarching lesson to be learned from COVID-19, it is that the country's investments in clinical care versus public health must be recalibrated. The inevitable barrier to that reform will be private healthcare's lobbyists who will argue for increased reimbursement for providers rather than channeling resources to social determinants, surveillance, and preventive care.

History likely will record the COVID-19 pandemic as a once-in-a century disaster, but that should not absolve the U.S. healthcare system from blame. The last few decades have provided multiple previews of the system's deficiencies and structural weaknesses that render it even less able to sustain a crisis: from Hurricane Katrina in 2005, to H1N1 in 2009, to the Ebola virus in 2014, and the height of the opioid overdose epidemic beginning in 2011. Some will argue that the loss of life seen in Italy, Spain, and the United Kingdom prove that a universal-coverage, single-payer system is not necessarily the solution for the United States. 83 More thoughtful analysis will conclude, however, that the pandemic exposed the deep flaws in our healthcare

system, 84 flaws that flow from a healthcare financing system that reflects individualism rather than solidarity. Those flaws were tragically encapsulated in a story related by a nurse anesthetist in New York City who memorialized the dying words of one of his COVID-19 patients as he was placed on a ventilator: "Who's going to pay for it?" 85

Medicaid and Opioids: From Promising Present to Perilous Future

Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, Pub. L. No. 116-123 (2020) and Coronavirus Aid, Relief, and Economic Security Act of 2020

The Root of the Problem: America's Social Determinants of Health, Hatch Foundation for Civility and Solutions

Dep't of Health & Hum. Servs., & Seema Verma

to State Medicaid Directors

to State Medicaid Directors

CMS Approves Medicaid Section 1135 Waivers for 11 Additional States in Response to COVID-19

approving waiver to allow geographic and population targeting but denying request to establish a temporary eligibility group for individuals with incomes at or below 200 percent FPL

Families First Coronavirus Response Act § 6004

§ 6008

Pandemic highlights value of Medicaid expansion in providing health care

A Preventable Cancer Is on the Rise in Alabama

Bus. v. Sebelius, 567

the American South, a Perfect Storm Is Gathering

Dems eye Medicaid incentives for next coronavirus rescue package

Whitmer stands out in the pandemic

Health Spending In OECD Countries: Obtaining Value Per Dollar, 27 HEALTH AFF

Remarks to the Centers for Consumer Information and Insurance Oversight's Industry Day

Understanding the Health Challenges Facing Rural Communities

More Rural Hospitals Closing in States Refusing Medicaid Coverage Expansion

Rural and Safety Net Hospitals Prepare for Cut in Federal Support

Anguished nurses say Pennsylvania hospital risked infecting cancer patients, babies and staff with covid-19

Amid Ongoing COVID-19 Pandemic, Governor Cuomo Announces Statewide Public-private Hospital Plan to Fight COVID-19

Bill Estep & Will Wright, Kentucky hospital chain furloughs about 500 employees as coronavirus saps business

US private health insurance companies clog system amid Covid-19 pandemic

Whitmer: Feds told vendors not to send medical supplies to Michigan

COVID-19 and the NHS-"a national scandal

Private hospitals will be made public for duration of coronavirus pandemic

Spanish government puts private healthcare firms at the orders of the regions

Italy Shows That Medicare for All Is No Cure for Coronavirus, Bloomberg